National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
L01BC02	5-FLUOROURACIL EBEWE	G	Fluorouracil - 1000mg/20ml	1000mg/20ml	Injectable concentrated solution	653,107 L.L
N01BB02	? 2% LIDOCAINE HCL USP	G	Lidocaine HCl - 2%	2%	Injectable solution	255,970 L.L
M01AE01	? IBUPROFEN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	383,955 L.L
P01AB01	? METRONIDAZOL	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L
C01CA03	? NORADRENALINE	G	Norepinephrine tartrate - 8mg/4ml	8mg/4ml	Injectable solution	330,201 L.L
N02BE01	? PARACETAMOL	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	191,978 L.L
N03AB02	? PHENYTOIN SODIUM 5% USP	G	Phenytoin (sodium) - 250mg/5ml	5ml	Injectable solution	276,448 L.L
D10BA01	A-CNOTREN	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,390,057 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
N02BE51	A.B.C.-COLD	G	Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg		Tablet, film coated	534,977 L.L
B01AC06	A.S HEART	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
N05AX12	ABIPREX 10	G	Aripiprazole - 10mg	10mg	Tablet	1,075,074 L.L
N05AX12	ABIPREX 15	G	Aripiprazole - 15mg	15mg	Tablet	1,075,074 L.L
L02BX03	ABIRATERONE ACETATE NEAPOLIS	G	Abiraterone acetate - 250mg	250mg	Tablet	197,778,023 L.L
L02BX03	ABIRATERONE ACETATE SPC	G	Abiraterone acetate - 250mg	250mg	Tablet, film coated	141,687,170 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	45,056,853 L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	45,056,853 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	77,478,802 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L

National Cancer Registry (NCR)